ProfileGDS5678 / 1451695_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 19.7392398
GSM967853U87-EV human glioblastoma xenograft - Control 210.216298
GSM967854U87-EV human glioblastoma xenograft - Control 39.9797798
GSM967855U87-EV human glioblastoma xenograft - Control 410.162998
GSM967856U87-EV human glioblastoma xenograft - Control 510.133698
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 19.6745298
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 29.7364698
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 310.253898
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 410.361898
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 110.214498
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 29.9170898
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 310.131998
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 49.9492498
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 510.055198